- EN
Generic name: Flurane Chloride Chewable Tablets
【Main Ingredient】Flurane
【Properties】This product is a round tablet, which is light brown to dark brown in color.
【Pharmacological Effects】Pharmacodynamics Fluraria is an insecticide and acaricide of the isoxazoline class. It works by antagonizing γ-aminobutyric acid receptors and glutamate receptors that gate chloride ion channels, preventing chloride ions from penetrating into the postsynaptic membrane and interfering with the transmembrane signal transmission of the nervous system, causing disruption of the insect's nervous system and subsequent death. Fluraria does not have cross-resistance with dieldrin. Fluraria is a systemic antiparasitic drug. Its effect of eliminating fleas and ticks from the dog's body lasts for 12 weeks. Fluraria has a killing effect on cat head lice and dog head lice. It takes effect quickly on adult fleas and has a long duration of action. It can also prevent flea egg production, thereby disrupting the flea's life cycle. Fluraria has a killing effect on soft tick (larvae, nymphs and adults), hexagonal hard tick, shoulder-tipped hard tick, full-circle hard tick, reticulate tick, variant tick and blood-red head tick. Pharmacokinetics Fluraria is easily absorbed when taken orally and reaches the maximum blood concentration within 1 day. Food can promote its absorption. Fluraria is distributed systemically, with the highest concentration in fat, followed by liver, kidneys and muscles. Fluraria is almost not metabolized in dogs. The plasma elimination half-life is approximately 12 days, allowing fluraria to maintain an effective blood concentration during the administration period. The maximum blood concentration and plasma elimination half-life vary among individuals. Approximately 90% of fluraria is excreted in feces as the original form, and a small amount is excreted through the kidneys.
【Indications】It is used for treating flea and tick infections on the dog's body, and can also assist in the treatment of allergic dermatitis caused by fleas.
【Usage and Dosage】Based on this product. Oral administration: For dogs, administer according to the weight range shown in the table. Give once every 12 weeks.
Product Description
Targeted Parasite Control for Veterinary and Wholesale Markets
Designed specifically for professional use, this Fluralaner chewable for dogs provides systemic protection against fleas and ticks, addressing the needs of veterinarians and pet medication wholesale distributors. Its oral formulation allows for straightforward administration, streamlining parasite control protocols in clinical and retail scenarios. By delivering precise dosing options from 112.5 mg up to 1400 mg, it meets the weight-specific requirements of various dog breeds, promoting accuracy in parasite management programs. This product integrates into broader veterinary care strategies, optimizing treatment cycles and compliance rates in professional and commercial environments.
Technical Specifications underpinned by Isoxazoline Innovation
The chewable dog flea medicine utilizes the isoxazoline class insecticide Fluralaner to achieve rapid absorption, reaching peak plasma concentrations within a day. Its systemic mechanism disrupts critical neural receptors in ectoparasites, ensuring paralysis and elimination of fleas and ticks. Available in weight-adjusted dosages, the formulation supports dosing intervals of 12 weeks, minimizing treatment frequency without compromising efficacy. Its pharmacokinetic profile favors fat-tissue retention, providing sustained protection. Rigorous quality controls during manufacturing uphold GMP standards, guaranteeing consistency and safety for veterinary applications.
Integration and Efficacy in Veterinary and Retail Contexts
This dog flea treatment chewable serves as a fundamental component of parasite control regimens in veterinary clinics, pet pharmacies, and wholesale distribution networks. It supports integrated pest management by targeting adult fleas and ticks and impairing flea reproduction to break the parasite life cycle. Its ease of use enhances client compliance, reducing follow-up visits and simplifying inventory for pet medicine manufacturers. The product's long-duration efficacy aligns with seasonal parasite emergence patterns, enabling streamlined scheduling for preventive care plans and bulk stock management in commercial pet health settings.
Product Advantages
Structural and Formulation Advantages Supporting Commercial Deployment
The product’s design aligns with veterinary supply chain and commercial distribution needs, featuring chewable tablets formulated for oral administration. The scalable strength variations (112.5 mg to 1400 mg) accommodate dogs of diverse sizes, promoting operational flexibility for pet medication wholesale distributors and clinics. The chewable format facilitates ease of integration into treatment protocols, improving dosing accuracy over topical or injectable alternatives. The formulation’s stability and shelf life conform to industry standards, supporting large-scale inventory management and minimizing product losses during shipment and storage.
Performance Reliability Enhancing Compliance and Return on Investment
This chewable for dogs assures consistent pharmacological action, delivering effective flea and tick control with a single dose lasting 12 weeks, which reduces the total number of treatments required per year. Such reduced dosing frequency enhances owner adherence and lowers clinic dispensing workload. The systemic action circumvents topical application limitations, ensuring that parasites absorbed systemically are eliminated efficiently. For pet medicine manufacturers and distributors, this translates to improved product reputation due to reliable performance and reduced returns. The palatable chewable form increases administration success rates, reinforcing the product’s value proposition in veterinary and retail markets.
Use Scenarios
Implementation in Veterinary Parasite Prevention Protocols
In veterinary clinical environments, this chewable dog flea medicine supports structured parasite control regimens by enabling veterinarians to prescribe long-acting, weight-specific doses tailored to individual patients. The product’s pharmacokinetics allow integration into routine check-ups, simplifying scheduling due to extended dosing intervals of 12 weeks. Clinics benefit from its user-friendly chewable format which aids in in-clinic demonstrations and owner instruction, improving compliance. Its broad-spectrum efficacy against fleas and multiple tick species aligns with clinical goals of comprehensive parasite management, ensuring adherence to established veterinary parasite control guidelines and minimizing parasite resistance risks.
Role in Wholesale Distribution for Optimized Inventory and Client Solutions
For pet medication wholesale distributors, this Fluralaner chewable for dogs facilitates inventory standardization by providing a range of strengths addressing multiple dog weight categories within a single product line. The product’s robust shelf life and stability reduce supply chain disruptions, while standardized packaging minimizes logistical complexity. Wholesale distribution channels leverage the product’s demonstrated performance and regulatory compliance to meet retailer demands efficiently. The chewable tablet delivery system streamlines product recommendations for end-users by retailers, enabling veterinarians and pet owners to implement efficacious parasite prevention plans with minimal training or complication.
FAQ
1. What is the MOQ?
